Category: Interviews
Breanna Deutsch Wants You to Contact Lawmakers About Aging
November 3, 2020
Today, we are interviewing Breanna Deutsch, a policy expert and the author of Finding the Fountain, which we have previously reviewed. Breanna comes from the world of political communications, and
Rick Kiessig Discusses VTose, a Broad-Spectrum Antiviral
September 25, 2020
Recently, we had the opportunity to interview Rick Kiessig, the co-founder of Kimer Med, a company developing a broad-spectrum antiviral that has the potential to destroy a wide range of
Are Epigenetic Clocks Ready for Prime Time?
July 22, 2020
Reason, author of the anti-aging blog Fight Aging and CEO of Repair Biotechnologies, still isn’t convinced that methylation is very useful in assessing biological age or the efficacy of various
A New Hallmark of Aging Proposed
July 15, 2020
Two researchers, Alexander Fedintsev and Alexey Moskalev, have published an expansive review paper in which they propose a new hallmark of aging [1]. The authors draw our attention to a
Edwina Rogers – Effective Advocacy for Longevity
July 6, 2020
We had the opportunity to interview Edwina Rogers, CEO of the Global Healthspan Policy Institute and a professional public health advocate supporting aging research. Edwina has degrees in corporate finance
Diluting Blood Plasma Rejuvenates Old Mice
June 16, 2020
Back in 2005, Drs. Irina and Michael Conboy showed that joining the circulatory systems of young and old mice together in a procedure called parabiosis could rejuvenate aged tissues and
The Moonshot Venture Fellowship
May 6, 2020
We had the opportunity to speak to Apollo Health Ventures about the Moonshot Venture Fellowship and about the aging research field in general from the perspective of a venture capital
The Paper That Helped Change WHO’s Position on Aging
May 5, 2020
We had the opportunity to interview Daria Khaltourina about a review written by her team, which recommended giving aging its own disease classification in the ICD-11. Back in 2018, an
Lewis Gruber – Senotherapeutics
February 11, 2020
At the recent Longevity Therapeutics Conference in San Francisco, we had the chance to interview Lewis Gruber of SIWA Therapeutics and discuss his company’s senotherapeutic approach to cancer and senescent
Hanadie Yousef – Embryonic Proteins for Tissue Regeneration
February 10, 2020
At the recent Longevity Therapeutics Conference in San Francisco, we had the chance to interview Hanadie Yousef, the co-founder and CEO of Juvena Therapeutics. Juvena is isolating proteins from embryonic
Irina & Michael Conboy – Making Old Blood Young Again
February 5, 2020
We were at the recent Longevity Therapeutics Conference in San Francisco, and we had the opportunity to interview Irina and Michael Conboy from UC Berkeley about their pioneering work on
Greg Potter on Biohacking and Lifestyle
December 17, 2019
We had the opportunity to interview Greg Potter, Ph.D., a researcher of lifestyle factors in health throughout life, at Biohacking Conference Moscow, which was hosted at the Congress Centre Technopolis
Brian Kennedy on Rapamycin, mTOR, and Interventions
December 4, 2019
If humans ever reach an average lifespan of well over 100 years, what is going to happen? Are we going to be bored with such long lives? “Well,” says Prof.
Ronald Kohanski of the NIA Discusses Potential Therapies
October 16, 2019
It was a pleasure speaking to Dr. Ronald Kohanski at the 2019 Ending Age-Related Diseases conference. Dr. Kohanski joined the field of aging research in 2005 as a Program Officer
Justin Rebo on BioAge and Biotech
October 4, 2019
At the Ending Age-Related Diseases 2019 Conference in New York City, we had the opportunity to interview Dr. Justin Rebo from the drug discovery biotech company BioAge. BioAge is developing
Breanna Deutsch Wants You to Contact Lawmakers About Aging
November 3, 2020
Today, we are interviewing Breanna Deutsch, a policy expert and the author of Finding the Fountain, which we have previously reviewed. Breanna comes from the world of political communications, and she explains what needs to be done to encourage policymakers to pave the way for a
Rick Kiessig Discusses VTose, a Broad-Spectrum Antiviral
September 25, 2020
Recently, we had the opportunity to interview Rick Kiessig, the co-founder of Kimer Med, a company developing a broad-spectrum antiviral that has the potential to destroy a wide range of viruses. Its drug, known as VTose, is a variant of an older antiviral drug known as
Are Epigenetic Clocks Ready for Prime Time?
July 22, 2020
Reason, author of the anti-aging blog Fight Aging and CEO of Repair Biotechnologies, still isn’t convinced that methylation is very useful in assessing biological age or the efficacy of various therapeutics, despite the wide use of methylation-based clocks. He surprised me at this year’s Longevity Therapeutics
A New Hallmark of Aging Proposed
July 15, 2020
Two researchers, Alexander Fedintsev and Alexey Moskalev, have published an expansive review paper in which they propose a new hallmark of aging [1]. The authors draw our attention to a phenomenon that is sometimes overlooked in the context of aging: the accumulation of damage to long-lived
Edwina Rogers – Effective Advocacy for Longevity
July 6, 2020
We had the opportunity to interview Edwina Rogers, CEO of the Global Healthspan Policy Institute and a professional public health advocate supporting aging research. Edwina has degrees in corporate finance and law. She worked for four U.S. Presidents and two U.S. Senators, helping to shape national
Diluting Blood Plasma Rejuvenates Old Mice
June 16, 2020
Back in 2005, Drs. Irina and Michael Conboy showed that joining the circulatory systems of young and old mice together in a procedure called parabiosis could rejuvenate aged tissues and reverse some aspects of aging in old mice. Following this discovery, many researchers concluded that there
The Moonshot Venture Fellowship
May 6, 2020
We had the opportunity to speak to Apollo Health Ventures about the Moonshot Venture Fellowship and about the aging research field in general from the perspective of a venture capital firm. Apollo Health Ventures is a life science venture capital firm and life science company builder
The Paper That Helped Change WHO’s Position on Aging
May 5, 2020
We had the opportunity to interview Daria Khaltourina about a review written by her team, which recommended giving aging its own disease classification in the ICD-11. Back in 2018, an international group of scientists filed a proposal with the World Health Organization to introduce aging as
Lewis Gruber – Senotherapeutics
February 11, 2020
At the recent Longevity Therapeutics Conference in San Francisco, we had the chance to interview Lewis Gruber of SIWA Therapeutics and discuss his company’s senotherapeutic approach to cancer and senescent cells. He was accompanied by his wife, Misty, who is the CFO of SIWA. Many of
Hanadie Yousef – Embryonic Proteins for Tissue Regeneration
February 10, 2020
At the recent Longevity Therapeutics Conference in San Francisco, we had the chance to interview Hanadie Yousef, the co-founder and CEO of Juvena Therapeutics. Juvena is isolating proteins from embryonic stem cells that promote tissue regrowth. Can you describe in more detail Juvena’s approach to developing
Irina & Michael Conboy – Making Old Blood Young Again
February 5, 2020
We were at the recent Longevity Therapeutics Conference in San Francisco, and we had the opportunity to interview Irina and Michael Conboy from UC Berkeley about their pioneering work on blood factors and aging. Irina is a member of our Scientific Advisory Board, and the Conboys’
Greg Potter on Biohacking and Lifestyle
December 17, 2019
We had the opportunity to interview Greg Potter, Ph.D., a researcher of lifestyle factors in health throughout life, at Biohacking Conference Moscow, which was hosted at the Congress Centre Technopolis Moscow on September 19th. In a provocative 2017 publication, Serge Faguet claimed to have spent $200,000
Brian Kennedy on Rapamycin, mTOR, and Interventions
December 4, 2019
If humans ever reach an average lifespan of well over 100 years, what is going to happen? Are we going to be bored with such long lives? “Well,” says Prof. Brian Kennedy of the National University of Singapore, “If you ask me: ‘Do I want to
Ronald Kohanski of the NIA Discusses Potential Therapies
October 16, 2019
It was a pleasure speaking to Dr. Ronald Kohanski at the 2019 Ending Age-Related Diseases conference. Dr. Kohanski joined the field of aging research in 2005 as a Program Officer for the Division of Aging Biology at the National Institute on Aging. He moved on to
Justin Rebo on BioAge and Biotech
October 4, 2019
At the Ending Age-Related Diseases 2019 Conference in New York City, we had the opportunity to interview Dr. Justin Rebo from the drug discovery biotech company BioAge. BioAge is developing a drug discovery platform that uses machine learning and artificial intelligence to discover targets that have